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Identity 
Other names: GFRP1, HMR, N10, NAK-1, NGFIB, 
NP10, NUR77, TR3 
HGNC (Hugo): NR4A1 
Location: 12q13.13 
Note 
This article is an update of: NR4A1, 2, 3--an orphan 
nuclear hormone receptor family involved in cell 
apoptosis and carcinogenesis (Li et al., 2006). 
DNA/RNA 
Description 
The NR4A1 gene is located on human chromosome 12 
at position 12q13.13.  
The gene spans from 52416616 to 52453291 (36.7 Kb) 
on the forward strand (NCBI). 
Transcription 
NR4A1 encodes three transcript variants and variant 3 
produces two protein isoforms. 
Variant 1 mRNA NCBI Reference number: 
NM_002135. 
Variant 2 mRNA NCBI Reference number: 
NM_173157. 




NR4A1 is a steroid/thyroid hormone-responsive orphan 
nuclear receptor that contains three key functional 
domains: a steroid hormone receptor ligand-
independent transactivation domain (AF-1), a nuclear 
hormone receptor zinc finger domain (ZnF_C4) and a 
hormone receptor ligand-binding domain (HOLI) 
(Figure).  
No natural ligand for NR4A1 has yet been identified 
(Davis and Lau, 1994; Mohan et al., 2012). NR4A1 is 
thought to play a role in transcriptional regulation 
through binding of the ZnF_C4 domain to hormone 
response elements in DNA (Moehren et al., 2004). This
domain contains multiple finger-like structures and 
interacts with several target molecules, including DNA, 
RNA, proteins, and/or lipid substrates (Laity et al., 
2001). The range of interactions implies that the 
ZnF_C4 domain has multiple functions in different 
molecular processes. The HOLI domain influences 
NR4A1 nuclear translocation and its association with 
DNA (Bledsoe et al., 2004). 
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Schematic diagram of NR4A1 showing its location on chromosome 12, its orientation relative to surrounding genes, and the three key 
functional domains of the protein. 
 
Expression 
NR4A1 has been detected at varying levels in different 
human tissues, with particularly high levels in the 
adrenal cortex, lungs, prostate, ovaries, testes, hart, 
muscle, thyroid, trachea, olfactory bulb and adrenal 
gland (Su et al., 2004). 
Localisation 
NR4A1 is a nuclear hormone receptor that is activated 
by association with its ligand to move into the nucle s. 
For example, in response to n-Butylidenephthalide 
induced cell death signals, NR4A1 translocates into 
mitochondria to enhance apoptosis (Chen et al., 2008; 
Liu et al., 2012). 
Function 
NR4A1 is involved in multiple molecular processes, 
including signal transmission, transcriptional 
regulation, mediation of cell growth, induction of 
apoptosis, and cell cycle control (Lee et al., 2011; 
McMorrow and Murphy, 2011; Mohan et al., 2012; van 
Tiel and de Vries, 2012). NR4A1 acts as a hormone 
receptor and is stimulated by ligand binding to move 
into the nucleus and associate with DNA to regulate 
transcription of multiple genes (Wu et al., 2002). 
NR4A1 is also involved in several complex pathways 
that mediate cell survival and apoptosis (Li et al., 2006; 
Lin et al., 2004).  
Furthermore, NR4A1 dysfunction has been associated 
with inflammation and carcinogenesis (Choi et al., 
2004; Li et al., 2006). In terms of post-translational 
modifications, NR4A1 is phosphorylated by protein 
kinase B at Serine 350 and its acetylation is modulated 
by p300 and HDAC1 (Kang et al., 2010; Pekarsky et 
al., 2001). 
Cell growth/survival 
As a steroid/thyroid hormone receptor, NR4A1 acts as 
a transcription factor, activating several genes involved 
in cell growth and survival (Bras et al., 2000). The 
expression of NR4A1 can be induced by tumor necrosis 
factor, growth factor, nerve growth factor and T-cell 
receptor-mediated signaling, implying a role of NR4A1 
in cell proliferation (Bras et al., 2000). In addition, 
nerve growth factor IB and nuclear receptor subfamily 
4 response elements, suggesting that NR4A1 functions 
in growth and cell cycle control (Pei et al., 2006). A 
dominant negative mutation in the transactivation 
domain of NR4A1 reduces cultured mouse embryonic 
cell growth in a tumor necrosis factor-dependent 
manner (Suzuki et al., 2003). Silencing of NR4A1 by 
siRNA treatment causes a dramatic reduction in 
growth/survival of HeLa, DLD1, HCT116, PC3, U87, 
and AsPC1 cell lines (Ke et al., 2004). Thus, NR4A1 
appear to be involved in cell growth and survival, but
the detailed mechanisms are still largely unknown. 
Apoptosis 
Contradictory to its apparent role in cell survival, 
NR4A1 also activates several genes involved in cell
apoptosis as well as translocating directly into 
mitochondria to enhance the apoptotic signal (Li et al., 
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2000; Lin et al., 2004; Zhang et al., 1999). For 
example, NR4A1 induces apoptosis in cultured prostate 
cancer cells through activation of the transcription 
factor E2F1 (Mu and Chang, 2003; Wilson et al., 
2003). NR4A1 also mediates apoptosis through 
translocation from the nucleus into mitochondria where 
it interacted with the apoptosis regulating protein Bcl-2 
to release cytochrome c (Lin et al., 2004; Suzuki et al., 
2003). Another apoptosis regulating protein, BAX, is 
thought to recruit NR4A1 into the mitochondria to 
mediate apoptosis (Wilson et al., 2003). NR4A1 furthe  
induces apoptosis by reacting with self-recognizing 
major histocompatibility complex molecules in T cell 
(Zhang et al., 1999). NR4A1 acts as an inflammatory 
factor in T-cell, and T-cell receptor-mediated apoptosis 
can be prevented by inhibiting NR4A1 function (Liu et 
al., 1994; Woronicz et al., 1994). Thus, it appears that 
NR4A1 plays different and opposing roles in cell 
survival and apoptosis depending on the cell status nd 
molecular environment (Mohan et al., 2012). 
Neuronal regulation 
GFP-tagged NR4A1 is associated with dopamine 
receptor D1 positive neurons in brain tissue of 
transgenic mice (Davis and Puhl, 2011). NR4A1 
activity closely correlates with dopamine 
neurotransmission in the central nervous system of 
mice (Gilbert et al., 2006). Furthermore, NR4A1 
induces immediate early genes within central nervous 
system cells and basal ganglia of adult mice (Heiman et 
al., 2008; Lobo et al., 2006). NR4A1 deficient mice 
exhibit dysfunctional locomotor behavior due to 
alteration of dopamine neuron activity (Gilbert et al., 
2006). Although NR4A1 is clearly involved in 
dopamine neuron activity, the specific mechanisms of 
this involvement remain unknown (Perlmann and 
Wallen-Mackenzie, 2004). 
Muscle homeostasis and metabolism 
In skeletal muscle, NR4A1 expression is enhanced by 
activation of the beta-adrenergic signaling pathway 
during muscle hypertrophy and endurance exercise 
(Mahoney et al., 2005; Maxwell et al., 2005; Pearen et 
al., 2006).  
Knockdown of NR4A1 by siRNA treatment causes 
repression of several genes associated with lipid, 
carbohydrate and glucose metabolism including the 
genes for AMP-activated protein kinase subunit gamm 
3, fatty acid translocase and glucose transporter 4 
(Maxwell et al., 2005; Chao et al., 2007).  
Interestingly, NR4A1 appears to influence energy 
balance and thermogenesis control through uncoupling 
of mitochondrial respiration (Kanzleiter et al., 2005). 
These findings suggest that NR4A1 is involved in 
energy metabolism and muscle energetics and function. 
Homology 
NR4A1 is an evolutionarily conserved gene and shows 
similar genomic synteny across species. The NR4A 
family includes three proteins (NR4A1, NR4A2 and 




No single site, nonsense or frameshift mutations in 
NR4A1 have been associated with cancer and/or 
disease in humans, but disruption of NR4A1 in mice by 
insertion of the neomycin resistance gene in exon 2 
leads to development of acute myeloid leukemia 
(Mullican et al., 2007). 
Implicated in 
Cancer and clinical translation 
Note 
It is well known that tumor growth depends on new 
blood vessel formation to facilitate nutrient delivry 
(Liu et al., 2003; Mohan et al., 2012). NR4A1 
expression is enhanced by vascular endothelial growth 
factor (Arkenbout et al., 2003; Liu et al., 2003). VEGF 
also stimulates CREB-dependent NR4A1 expression 
which in turn enhances angiogenesis through its 
transcription factor activity (Zeng et al., 2006; Zhao et 
al., 2011b). In addition, NR4A1 is activated by 
overexpression of hypoxia-inducible factor-1 alpha and 
thereby promotes overproduction of the hormone 
precursor proopiomelanocortin in VHL-mutated renal 
cell carcinoma (Choi et al., 2004).  
Although the studies cited above indicate that NR4A1 
contributes to carcinogenesis, many others report the 
opposite effect of NR4A1 on tumor growth (Mohan et 
al., 2012). NR4A1 expression is modified to inhibit 
tumor formation in many tumor types, including colon, 
breast, bladder, liver, thyroid, lung, prostate, and renal 
cell carcinoma (Choi et al., 2004; Mohan et al., 2012; 
Mu and Chang, 2003). As noted earlier, NR4A1 
promotes apoptosis in a human prostate cancer cell line 
through stimulation of E2F1 expression (Mu and 
Chang, 2003). Early induction of NR4A1 in a human 
breast cancer cell line causes A23187-induced cell 
death via the CREB signaling pathway (Ohkubo et al., 
2000). Recruitment of NR4A1 to the mitochondria and 
the subsequent release of cytochrome c have been 
associated with the Bcl-2 apoptotic pathway in several 
different cancer cell types (Lin et al., 2004; Wilson et 
al., 2003). NR4A1 enhances p53 transactivation of 
ionizing radiation-induced apoptosis in hepatoma cells, 
indicating that it may be a potential target for can er 
radiotherapy (Zhao et al., 2011a). Loss of NR4A1 
correlates with malignancy in follicular thyroid 
carcinomas presumably due to the reduction in 
apoptosis that allows cell growth (Camacho et al., 
2009). Retinoic acid receptors (RARs) are often lost
during carcinogenesis. NR4A1 was found to form 
apoptosis-inducing heterodimers with RARs in cultured 
lung cancer cells (Wu et al., 1997). Up-regulation of  
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NR4A1 and the resulting increase in apoptosis of 
human hepatocellular carcinoma cells is also RARβ 
dependent (Yang et al., 2011).  
NR4A1 has begun to be incorporated into new cancer 
therapeutic strategies. These therapies rely on apoptosis 
induced by NR4A1 mitochondrial localization (Lin et
al., 2004; Mohan et al., 2012). For example, 
glioblastoma multiforme is inhibited by local interstitial 
delivery of z-butylidenephthalide, which enhances 
NR4A1 expression and translocation into mitochondria 
(Harn et al., 2011; Lin et al., 2008). N-
butylidenephthalide derivative also inhibit cell growth 
in hepatocellular carcinoma, oral squamous cell 
carcinoma and balloon injured rat carotid artery by 
inducing apoptosis (Chen et al., 2008; Liu et al., 2011; 
Liu et al., 2012). Moreover, 1,1-Bis(3'-indolyl)-1-(p
substituted phenyl)methanes induce apoptosis throug 
NR4A1 activation in cultured pancreatic carcinoma 
cells (Chintharlapalli et al., 2005). 
To be noted 
Note 
Acknowledgements, Taiwan Department of Health 
Clinical Trial and Research Center of Excellence 
(DOH101-TD-B-111-004). 
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